IVF Devices and Consumables Market to reach USD USD 19,844.83 million by 2031-growing at a CAGR of 21.7%, Application segment holds 75% market revenue, North America led 35% share of global market.

IVF Devices and Consumables Market size was valued USD 2,147 million in 2024 and is estimated to reach USD 19,844.83 million by 2031, growing at a CAGR of 21.7% during the forecast period (2025-2031). IVF is a type of assisted reproductive technology used for infertility treatment and gestational surrogacy.

As per DataM Intelligence, IVF Devices and Consumables Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global IVF Devices and Consumables Market size, and growth, along with the latest trends, opportunities, and forecast till 2030 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/ivf-devices-and-consumables-market?pratik

United States: Key Industry Developments
✅ October 2025: CooperSurgical, Inc. launched a new line of automated embryo transfer catheters and micromanipulation systems, improving accuracy and reducing embryo damage risk during IVF procedures.

✅ September 2025: Thermo Fisher Scientific introduced AI-powered incubators with environmental sensors to precisely control humidity and temperature for optimal embryo development in IVF labs.

✅ August 2025: Vitrolife AB collaborated with Stanford Medicine on a digital IVF workflow platform using time-lapse imaging and AI predictions to enhance clinical success rates.

Japan: Key Industry Developments
✅ October 2025: Kitazato Corporation introduced pre-validated vitrification media kits for oocyte and embryo cryopreservation, simplifying lab prep while preserving cellular integrity.

✅ September 2025: Fujifilm Irvine Scientific unveiled next-generation culture media with advanced nutrient formulations to support embryo growth and minimize oxidative stress.

✅ August 2025: Fujifilm Irvine Scientific acquired a regional distributor of fertility consumables to expand market presence and streamline IVF media and reagent distribution.

FDA approvals
→ Fairtility received U.S. FDA clearance for its Chloë AI embryo-assessment platform on September 5, 2025 the clearance allows Fairtility to offer its AI-driven embryo scoring and decision-support tools to U.S. IVF clinics, marking one of the first AI embryo-assessment systems cleared for use in American fertility practice.

→ Esco Medical's MIRI TL (or MIRI M multiroom) IVF incubator line was granted FDA 510(k) clearance on October 14, 2025, enabling marketing of the company's multiroom incubator and related IVF-lab automation modules in the U.S.; the clearance supports wider adoption of standardized, MEA-tested incubator systems in clinical embryology labs.

Mergers & Acquisitions (selected 2025 activity paragraph format, includes dates)
→ Trans Ova Genetics acquired ReproLogix (effective September 18, 2025). Trans Ova a major provider of advanced reproductive technologies in the livestock sector bought ReproLogix to expand its embryo-transfer and IVF services footprint, strengthening capacity and regional service coverage for animal-reproduction customers.

→ INVO Fertility announced its intent to acquire Family Beginnings, P.C. (deal announced November 28, 2025). INVO's announcement advances the company's U.S. clinic expansion strategy, adding a Midwest clinic to its network and broadening patient access to INVO's INVOcell and other fertility solutions.

→ NewGen completed an IP acquisition (reported October 6, 2025). NewGen reported a gain from an intellectual-property acquisition that positions the company to broaden its IVF technology and hardware offerings a strategic move to deepen its product portfolio for fertility clinics and services.

→ Creation Science IVF was acquired by Indira IVF (acquisition reported September 23, 2025). The transaction is part of Indira IVF's continuing consolidation strategy in India, expanding its clinic network and regional service capabilities across states.

"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=ivf-devices-and-consumables-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

Market Segmentation-
→ By Application: Assisted Reproductive Technology (ART) led with 75% share in 2024; Research and Academic Institutes poised for strong growth.​

→ By Technology: Conventional IVF captured 55% in 2024 due to high success rates and established use.​

→ By End Use: Fertility clinics dominated at 65% in 2024, supported by rising infertility awareness and specialized infrastructure.​

→ By Distribution: Distributors and Dealers held 55% in 2024 for efficient supply chain access.

Key Developments:-
→ In July 2025, Cook Medical expanded its IVF consumables portfolio by launching sterile, precision-engineered oocyte retrieval needles with improved ergonomics for enhanced clinician safety and efficiency.​

→ In August 2025, Vitrolife AB collaborated with Stanford Medicine to test a digital IVF workflow platform combining time-lapse imaging with AI prediction to boost clinical success rates, while Esco Micro Pte Ltd. established a research collaboration with Japanese fertility clinics to develop compact automation systems for mid-sized IVF laboratories.​

→ In October 2025, Vitrolife AB acquired a U.S.-based digital fertility analytics company to enhance its portfolio in data-driven IVF cycle optimization and streamline lab automation, and CooperSurgical completed its acquisition of a fertility equipment manufacturer specializing in disposable IVF instruments to boost consumables production capacity

Regional insights:-

• North America - 35%
North America (led by the U.S.) remains the largest regional market for IVF devices & consumables due to high procedure volumes, established fertility clinics, favorable reimbursement in many settings, and strong adoption of advanced lab equipment (time-lapse incubators, ICSI tools, embryo-biopsy kits, closed-system warming/cryopreservation consumables).

• Asia-Pacific - 30%
Asia-Pacific is the fastest-growing regional market and holds a large share driven by rising infertility prevalence, expanding clinic networks (China, India, Japan, South Korea), increasing medical tourism, government/private investments in ART infrastructure, and growing affordability and awareness. Growth momentum is strong, so its share is expected to rise further.

• Europe - 20%
Europe is a mature but sizeable market supported by high per-clinic procedure rates in Western Europe, advanced embryology labs, broad availability of diagnostic & genetic testing (PGT), and evolving reimbursement/coverage policies across countries - resulting in steady market share and strong demand for premium devices and disposables.

Competitive Landscape:-
→ Cook Medical Inc., IVF Store, Fujifilm Holdings Corporation, Merck KGaA, Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc. (CooperSurgical, Inc.), Thermo Fisher Scientific, Inc., and Vitrolife AB.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/ivf-devices-and-consumables-market?pratik

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.